Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study

INTRODUCTION: In clinical practice, nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly discontinued after response to biologic therapy is achieved in patients with axial spondyloarthritis (axSpA), but the impact of NSAID discontinuation has not been assessed in prospective controlled trials....

Descripción completa

Detalles Bibliográficos
Autores principales: Dougados, Maxime, Wood, Emily, Combe, Bernard, Schaeverbeke, Thierry, Miceli-Richard, Corinne, Berenbaum, Francis, Koppiker, Nandan, Dubanchet, Arnaud, Logeart, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282738/
https://www.ncbi.nlm.nih.gov/pubmed/25428762
http://dx.doi.org/10.1186/s13075-014-0481-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282738/
https://www.ncbi.nlm.nih.gov/pubmed/25428762
http://dx.doi.org/10.1186/s13075-014-0481-5

Ejemplares similares